Do Analysts Agree Tuesday on Arena Pharmaceuticals, Inc. (ARNA) Stock's Target Price?

Tuesday, September 07, 2021 01:59 PM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree Tuesday on Arena Pharmaceuticals, Inc. (ARNA) Stock's Target Price?

InvestorsObserver is giving Arena Pharmaceuticals, Inc. (ARNA) an Analyst Rating Rank of 75, meaning ARNA is ranked higher by analysts than 75% of stocks. The average price target for ARNA is $97.428 and analyst’s rate the stock as a Strong Buy.

Wall Street analysts are rating ARNA a Strong Buy today. Find out what this means to you and get the rest of the rankings on ARNA!

See Full ARNA Report

Why are Analyst Ratings Important?

Analytical research by professionals can be extremely useful when making investment decisions in the stock market. Analysts are able to observe industries in detail and learn how geographical impacts can affect a company's balance sheet. This information allows investors to make decisions ahead of the curve. InvestorsObserver combines the ratings from these analysts and proceeds to percentile rank them. This grants you the ability to compare stocks in a comprehensive fashion as oppossed to a standard buy/hold/sell rating.

What's Happening With Arena Pharmaceuticals, Inc. Stock Today?

Arena Pharmaceuticals, Inc. (ARNA) stock is higher by 0.18% while the S&P 500 is down -0.14% as of 1:57 PM on Tuesday, Sep 7. ARNA has gained $0.11 from the previous closing price of $60.25 on volume of 229,343 shares. Over the past year the S&P 500 has risen 35.94% while ARNA is down -7.08%. ARNA lost -$8.17 per share the over the last 12 months. Click Here to get the full Stock Report for Arena Pharmaceuticals, Inc. stock.